As enclosed herewith.

Nukleus Office Solutions Limited CIN NO -L70101DL2019PLC355618 │PH: +91-9667049487│ Email: cs@nukleus.work│ Website: www.nukleus.work│ Date: September 03, 2026 BSE Limited Phiroze Jeejeebhoy Towers Dalal Street, Mumbai – 400 001 Scrip Code: 544370 Sub.: Notice of the 7th Annual General Meeting of Nukleus Office Solutions Limited (the Company) for FY 2025-26. Ref: Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 Dear Sir/Ma’am, Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed Notice along with Explanatory Statement of the 7th Annual General Meeting of the Company to be held on Friday, September 25, 2026, at 11.30 A.M. (IST) through Video Conferencing (VC) / Other Audio Visual Means (OAVM). The said Notice forms part of the Annual Report FY 2025-26. The Annual Report for FY 2025-26 is being made available on the website of the Company at https://www.nukleus.work/investor-relations/. The above is for your information and record. Thanking You, For Nukleus Office Solutions Limited Vinay Rathore (Company Secretary & Compliance Officer) Membership No. 75848 Regd. Office: 1102, Barakhamba Tower, 22 Barakhamba Road, Connaught Place, New Delhi, Central Delhi- 110001, Delhi Corporate Office: Plot No 29, Sector -142, Noida, UP – 201305 Nukleus Office Solutions Limited CIN NO - L70101DL2019PLC355618 │PH: +91-9667049487│ Email: cs@nukleus.work │ Website: www.nukleus.work│ NOTICE NOTICE IS HEREBY GIVEN THAT THE 7TH ANNUAL GENERAL MEETING OF THE MEMBERS OF NUKLEUS OFFICE SOLUTIONS LIMITED WILL BE HELD ON FRIDAY, 25TH SEPTEMBER, 2026 AT 11:30 A.M. (IST) THROUGH VIDEO CONFERENCING (“VC”)/OTHER AUDIO-VISUAL MEANS (“OAVM”), TO TRANSACT THE FOLLOWING BUSINESS: ORDINARY BUSINESS: 1. To receive, consider and adopt the Audited Financial Statements of the Company for the financial year ended March 31, 2026, together with the Reports of the Board of Directors and the Auditors thereon. To consider and, if thought fit, to pass with or without modification(s), the following Resolution as an Ordinary Resolution: “RESOLVED THAT the Audited Financial Statements of the Company for the Financial Year ended March 31, 2026, including the Balance Sheet as at March 31, 2026, the Statement of Profit & Loss and Cash Flow Statement for the financial year ended on March 31, 2026, together with the notes to financial statements, reports of the Board of Directors and Auditors thereon, be and are hereby received, considered and adopted.” 2. To appoint a Director in place of Mr. Nipun Gupta (DIN: 00472330), who retires by rotation and being eligible, offers himself for re-appointment. To consider and, if thought fit, to pass with or without modification(s), the following Resolution as an Ordinary Resolution: “RESOLVED THAT pursuant to the provisions of Section 152 and other applicable provisions, if any, of the Companies Act, 2013 and the rules made thereunder (including any statutory modification(s) or re-enactment(s) thereof, for the time being in force), and Articles of Association of the Company, Mr. Nipun Gupta (DIN: 00472330), who retires by rotation at this Annual General Meeting, and being eligible, offers himself for re-appointment, be and is hereby re-appointed as a Director of the Company, liable to retire by rotation. Regd. Office : 1102, Barakhamba Tower, 22 Barakhamba Road, Connaught Place, New Delhi, Central Delhi- 110001, Delhi Corporate Office: Plot No 29, Sector -142, Noida, UP – 201305 Nukleus Office Solutions Limited CIN NO - L70101DL2019PLC355618 │PH: +91-9667049487│ Email: cs@nukleus.work │ Website: www.nukleus.work│ SPECIAL BUSINESS: 3. To approve the implementation of the NUKLEUS OFFICE SOLUTIONS LIMITED Employee Stock Option Scheme – I 2026 (“ESOP Scheme”) To consider and, if thought fit, to pass with or without modification(s), the following Resolution as an Special Resolution: “RESOLVED THAT pursuant to the provisions of Section 62(1)(b) and other applicable provisions, if any, of the Companies Act, 2013 (“Act”), read with Regulation 6 and other applicable provisions of the Securities and Exchange Board of India (Share Based Employee Benefits and Sweat Equity) Regulations, 2021 (“SEBI SBEB & SE Regulations”), the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, and the Articles of Association of the Company, and subject to such approvals, permissions, sanctions and conditions as may be necessary from the concerned statutory, regulatory and other authorities, consent of the Members of the Company be and is hereby accorded by way of Special Resolution for the introduction and implementation of the NUKLEUS OFFICE SOLUTIONS LIMITED ESOP Scheme–I 2026 (“ESOP Scheme”), and for grant of Employee Stock Options (“Options”) to eligible employees of the Company, as may be permitted under the applicable Laws, on the terms set out in the Explanatory Statement annexed to the Notice. RESOLVED FURTHER THAT the Board of Directors (“Board”), which term shall include the Nomination and Remuneration Committee/compensation committee) be and is hereby authorised to grant 2,01,600 (Two Lakh One Thousand Six Hundred) Options, each convertible into one (1) fully paid-up equity share of face value ₹ 10/- each, representing approximately 5% of the issued and paid-up equity share capital of the Company as on the date of this resolution to eligible employees, on such terms as the Board/Committee may determine in accordance with the ESOP Scheme and applicable law. RESOLVED FURTHER THAT each option granted under the Scheme shall confer upon the eligible employee the right, but not the obligation, to apply for and acquire one fully Regd. Office : 1102, Barakhamba Tower, 22 Barakhamba Road, Connaught Place, New Delhi, Central Delhi- 110001, Delhi Corporate Office: Plot No 29, Sector -142, Noida, UP – 201305 Nukleus Office Solutions Limited CIN NO - L70101DL2019PLC355618 │PH: +91-9667049487│ Email: cs@nukleus.work │ Website: www.nukleus.work│ paid-up equity share of the Company, subject to the terms and conditions of the Scheme. RESOLVED FURTHER THAT the options granted under the Scheme shall vest over such period and in such manner as may be determined by the Compensation Committee/Board, provided that the minimum vesting period shall be in accordance with the applicable provisions of the SEBI SBEB & SE Regulations. RESOLVED FURTHER THAT the exercise price of the options shall be determined in accordance with the Scheme and applicable laws and regulations, and shall be subject to such terms, conditions, discounts, premium or other parameters as may be approved by the Compensation Committee within the framework approved by the Members. RESOLVED FURTHER THAT the equity shares to be issued and allotted upon exercise of the options shall rank pari passu in all respects with the existing equity shares of the Company, including in respect of voting rights and dividend entitlement, from the date of allotment, subject to applicable laws. RESOLVED FURTHER THAT in case of any corporate action such as bonus issue, rights issue, stock split, consolidation, merger, demerger, reorganization, variation of capital or any other corporate action, the number of options, exercise price and/or other terms of the Scheme shall be appropriately adjusted in accordance with the applicable provisions of the SEBI SBEB & SE Regulations and the Scheme. RESOLVED FURTHER THAT the Compensation Committee be and is hereby authorised to determine the eligibility criteria, identify eligible employees, determine the number of options to be granted to each eligible employee, determine the vesting schedule and conditions, exercise period and procedure, treatment of options upon resignation, retirement, death, permanent incapacity or termination of employment, and all other matters necessar [Showing first 8,000 characters — download PDF for full document]